NO20051694L - Heterosykliske forbindelser - Google Patents
Heterosykliske forbindelserInfo
- Publication number
- NO20051694L NO20051694L NO20051694A NO20051694A NO20051694L NO 20051694 L NO20051694 L NO 20051694L NO 20051694 A NO20051694 A NO 20051694A NO 20051694 A NO20051694 A NO 20051694A NO 20051694 L NO20051694 L NO 20051694L
- Authority
- NO
- Norway
- Prior art keywords
- heterocyclic compounds
- alkyl
- benzoinidazol
- nethanone
- histamine
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/52—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
- C07D263/54—Benzoxazoles; Hydrogenated benzoxazoles
- C07D263/58—Benzoxazoles; Hydrogenated benzoxazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
- C07D277/62—Benzothiazoles
- C07D277/68—Benzothiazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
- C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
- C07D451/04—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof with hetero atoms directly attached in position 3 of the 8-azabicyclo [3.2.1] octane or in position 7 of the 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Immunology (AREA)
- Pulmonology (AREA)
- Biomedical Technology (AREA)
- Dermatology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Rheumatology (AREA)
- Physical Education & Sports Medicine (AREA)
- Urology & Nephrology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Pain & Pain Management (AREA)
- Otolaryngology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US40856902P | 2002-09-06 | 2002-09-06 | |
PCT/US2003/027461 WO2004022060A2 (fr) | 2002-09-06 | 2003-09-04 | Composes heterocycliques |
Publications (1)
Publication Number | Publication Date |
---|---|
NO20051694L true NO20051694L (no) | 2005-04-05 |
Family
ID=31978632
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20051694A NO20051694L (no) | 2002-09-06 | 2005-04-05 | Heterosykliske forbindelser |
Country Status (20)
Country | Link |
---|---|
US (1) | US7504426B2 (fr) |
EP (1) | EP1545532A2 (fr) |
JP (1) | JP2006500390A (fr) |
KR (1) | KR20050033662A (fr) |
CN (1) | CN1694704A (fr) |
AR (1) | AR041170A1 (fr) |
AU (1) | AU2003265886A1 (fr) |
BR (1) | BR0314059A (fr) |
CA (1) | CA2497827A1 (fr) |
EC (1) | ECSP055647A (fr) |
IS (1) | IS7716A (fr) |
MX (1) | MXPA05002575A (fr) |
NO (1) | NO20051694L (fr) |
NZ (1) | NZ538401A (fr) |
PL (1) | PL377087A1 (fr) |
RS (1) | RS20050201A (fr) |
RU (1) | RU2005106274A (fr) |
UA (1) | UA79309C2 (fr) |
WO (1) | WO2004022060A2 (fr) |
ZA (1) | ZA200502750B (fr) |
Families Citing this family (46)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6566372B1 (en) * | 1999-08-27 | 2003-05-20 | Ligand Pharmaceuticals Incorporated | Bicyclic androgen and progesterone receptor modulator compounds and methods |
EP3000810B1 (fr) | 2002-03-13 | 2017-07-19 | Array Biopharma, Inc. | Dérivé de benzimidazole d'alkylat n3 en tant qu'inhibiteur de mek |
CA2497788A1 (fr) * | 2002-09-06 | 2004-03-18 | Janssen Pharmaceutica, N.V. | Utilisation de modulateurs du recepteur h4 de l'histamine pour le traitement des allergies et de l'asthme |
EP1479676A1 (fr) * | 2003-05-19 | 2004-11-24 | Aventis Pharma Deutschland GmbH | Dérivés de benzimidazole en tant qu'inhibiteurs du facteur Xa |
US7741341B2 (en) | 2003-05-19 | 2010-06-22 | Sanofi-Aventis Deutschland Gmbh | Benzimidazole-derivatives as factor Xa inhibitors |
JP2007506983A (ja) * | 2003-09-26 | 2007-03-22 | ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ | 全血においてヒスタミンh4受容体により媒介される作用を分析すること |
WO2006031929A2 (fr) | 2004-09-15 | 2006-03-23 | Janssen Pharmaceutica, N.V. | Inhibiteurs de thiazolopyridine kinase |
EP1846409A1 (fr) * | 2004-11-24 | 2007-10-24 | Pfizer Limited | Dérivés d' octahydropyrrolo[3,4-c]pyrrole |
RS51423B (en) | 2006-03-31 | 2011-02-28 | Janssen Pharmaceutica N.V. | BENZOIMIDAZOL-2-IL PYRIMIDINI I KAO PYRAZID MODULATORS HISTAMINSKOG H4 RECEPTOR |
JP5132673B2 (ja) * | 2006-04-07 | 2013-01-30 | ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ | ヒスタミンh4受容体のモジュレーターとしてのインドールおよびベンゾイミダゾール |
US20090069343A1 (en) * | 2006-04-10 | 2009-03-12 | Dunford Paul J | Combination Histamine H1R and H4R Antagonist Therapy for Treating Pruritus |
EP2079694B1 (fr) | 2006-12-28 | 2017-03-01 | Rigel Pharmaceuticals, Inc. | Composés d'hétérocycloalkyloxybenzamide n-substitués, et procédés d'utilisation |
CA2727627C (fr) * | 2008-06-12 | 2018-02-13 | Janssen Pharmaceutica Nv | Utilisation de l'antagoniste de l'histamine h4 dans le traitement d'adhesions post-operatoires |
US9371311B2 (en) | 2008-06-30 | 2016-06-21 | Janssen Pharmaceutica Nv | Benzoimidazol-2-yl pyrimidine derivatives |
EP2201982A1 (fr) | 2008-12-24 | 2010-06-30 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Antagonistes du récepteur H4 de l'histamine pour le traitement de troubles vestibulaires |
US20120277238A1 (en) * | 2009-07-31 | 2012-11-01 | Shionogi & Co., Ltd | Pharmaceutical composition containing fused hetero-ring derivative |
CA2771592A1 (fr) * | 2009-09-04 | 2011-03-10 | Zalicus Pharmaceuticals Ltd. | Derives heterocycliques substitues pour le traitement de la douleur et de l'epilepsie |
TW201200518A (en) | 2010-03-10 | 2012-01-01 | Kalypsys Inc | Heterocyclic inhibitors of histamine receptors for the treatment of disease |
RS54514B1 (en) | 2010-09-02 | 2016-06-30 | Suven Life Sciences Limited | HETEROCYCLIC UNITS AS HISTAMINE H3 LEGANDS OF THE RECEPTOR |
US8859550B2 (en) | 2011-09-12 | 2014-10-14 | Kalypsys, Inc. | Heterocyclic inhibitors of histamine receptors for the treatment of disease |
CN102512421B (zh) * | 2011-10-28 | 2013-11-06 | 中国科学院广州生物医药与健康研究院 | 哌嗪酰胺类化合物在制药中的应用 |
SG11201402660YA (en) | 2011-12-21 | 2014-10-30 | Novira Therapeutics Inc | Hepatitis b antiviral agents |
PT2858647T (pt) | 2012-06-08 | 2018-10-03 | Sensorion | Inibidores do recetor h4 para tratamento de tinido |
KR102122244B1 (ko) | 2012-08-28 | 2020-06-15 | 얀센 사이언시즈 아일랜드 언리미티드 컴퍼니 | 설파모일-아릴아미드 및 b형 간염 치료제로서의 그 용도 |
AU2014222641B2 (en) | 2013-02-28 | 2018-03-15 | Janssen Sciences Ireland Uc | Sulfamoyl-arylamides and the use thereof as medicaments for the treatment of Hepatitis B |
US10208023B2 (en) | 2013-03-01 | 2019-02-19 | Mark G. DeGiacomo | Heterocyclic inhibitors of the sodium channel |
MX2015011688A (es) | 2013-03-06 | 2015-12-07 | Janssen Pharmaceutica Nv | Moduladores benzoimidazol-2-il pirimidinas del receptor h4 de histamina. |
WO2014165128A2 (fr) | 2013-03-12 | 2014-10-09 | Novira Therapeutics, Inc. | Agents antiviraux contre l'hépatite b |
MX353412B (es) | 2013-04-03 | 2018-01-10 | Janssen Sciences Ireland Uc | Derivados de n-fenil-carboxamida y su uso como medicamentos para el tratamiento de la hepatitis b. |
JO3603B1 (ar) | 2013-05-17 | 2020-07-05 | Janssen Sciences Ireland Uc | مشتقات سلفامويل بيرولاميد واستخدامها كادوية لمعالجة التهاب الكبد نوع بي |
CN108047115B (zh) | 2013-07-25 | 2021-06-29 | 爱尔兰詹森科学公司 | 经乙醛酰胺取代的吡咯酰胺衍生物及其作为药物用于治疗乙型肝炎的用途 |
EA034448B1 (ru) | 2013-10-23 | 2020-02-10 | Янссен Сайенсиз Айрлэнд Юси | Производные карбоксамида и их применение в качестве медикаментов для лечения гепатита b |
US10392349B2 (en) | 2014-01-16 | 2019-08-27 | Novira Therapeutics, Inc. | Azepane derivatives and methods of treating hepatitis B infections |
US9169212B2 (en) | 2014-01-16 | 2015-10-27 | Novira Therapeutics, Inc. | Azepane derivatives and methods of treating hepatitis B infections |
US9181288B2 (en) | 2014-01-16 | 2015-11-10 | Novira Therapeutics, Inc. | Azepane derivatives and methods of treating hepatitis B infections |
KR20160128305A (ko) | 2014-02-05 | 2016-11-07 | 노비라 테라퓨틱스, 인코포레이티드 | Hbv 감염의 치료를 위한 병용 요법 |
US11078193B2 (en) | 2014-02-06 | 2021-08-03 | Janssen Sciences Ireland Uc | Sulphamoylpyrrolamide derivatives and the use thereof as medicaments for the treatment of hepatitis B |
WO2015127549A1 (fr) * | 2014-02-27 | 2015-09-03 | Hassan Pajouhesh | Inhibiteurs hétérocycliques du canal sodique |
US9400280B2 (en) | 2014-03-27 | 2016-07-26 | Novira Therapeutics, Inc. | Piperidine derivatives and methods of treating hepatitis B infections |
US9884831B2 (en) | 2015-03-19 | 2018-02-06 | Novira Therapeutics, Inc. | Azocane and azonane derivatives and methods of treating hepatitis B infections |
US10875876B2 (en) | 2015-07-02 | 2020-12-29 | Janssen Sciences Ireland Uc | Cyclized sulfamoylarylamide derivatives and the use thereof as medicaments for the treatment of hepatitis B |
CN108430971A (zh) | 2015-09-29 | 2018-08-21 | 诺维拉治疗公司 | 乙型肝炎抗病毒剂的晶体形式 |
AU2017248828A1 (en) | 2016-04-15 | 2018-11-01 | Janssen Sciences Ireland Uc | Combinations and methods comprising a capsid assembly inhibitor |
CN111867582A (zh) | 2018-03-14 | 2020-10-30 | 爱尔兰詹森科学公司 | 衣壳组装调节剂给药方案 |
CA3127152A1 (fr) | 2019-02-22 | 2020-08-27 | Janssen Sciences Ireland Unlimited Company | Derives d'amide utiles dans le traitement d'une infection par le virus de l'hepatite b ou de maladies induites par le virus de l'hepatite b |
CA3132554A1 (fr) | 2019-05-06 | 2020-11-12 | Bart Rudolf Romanie Kesteleyn | Derives d'amide utiles dans le traitement d'une infection par le virus de l'hepatite b ou de maladies induites par le virus de l'hepatite b |
Family Cites Families (33)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BE791501A (fr) | 1971-11-19 | 1973-05-17 | Albert Ag Chem Werke | Diamines cycliques n,n'-disubstituees et leur procede de preparation |
US4115569A (en) * | 1971-11-19 | 1978-09-19 | Hoechst Aktiengesellschaft | Cyclic diamine derivatives |
SU1074094A1 (ru) | 1982-07-30 | 1992-04-23 | Научно-исследовательский институт фармакологии АМН СССР | Гидрохлорид 4-бензилпиперазида 3-метилбензофуран-2-карбоновой кислоты, обладающий психотропной активностью |
JPS5936670A (ja) * | 1982-08-25 | 1984-02-28 | Takeda Chem Ind Ltd | ベンゾチアゾ−ル誘導体,その製造法およびそれを含有する摂食抑制剤 |
US4490373A (en) * | 1983-05-20 | 1984-12-25 | Usv Pharmaceutical Corporation | Method of treating asthma |
DE3708292A1 (de) * | 1987-03-14 | 1988-09-29 | Basf Ag | Gegen einwirkung von licht stabilisierte polymere sowie neue imidazol-2-carbonsaeureanilide |
JPH01132579A (ja) | 1987-11-19 | 1989-05-25 | Ss Pharmaceut Co Ltd | インドール誘導体 |
US4937246A (en) | 1987-11-25 | 1990-06-26 | Takeda Chemical Industries, Ltd. | PAF antagonist, 1,4-disubstituted piperazine compounds and production thereof |
DK733788A (da) | 1988-01-14 | 1989-07-15 | Fujisawa Pharmaceutical Co | Indolylpiperidinderivater og fremgangsmaade til fremstilling deraf |
GB8827189D0 (en) | 1988-11-21 | 1988-12-29 | Fujisawa Pharmaceutical Co | 2(1h)-quinolinone compounds processes for preparation thereof & pharmaceutical composition comprising same |
US5563142A (en) * | 1989-12-28 | 1996-10-08 | The Upjohn Company | Diaromatic substituted compounds as anti-HIV-1 agents |
DK0507861T3 (fr) | 1989-12-28 | 1997-03-03 | Upjohn Co | |
HUT64320A (en) * | 1990-12-14 | 1993-12-28 | Merrell Dow Pharma | Process for production antiallergic imidazole derivatives and pharmaceutical preparations containing these compounds |
JPH0525131A (ja) | 1991-07-17 | 1993-02-02 | Toray Ind Inc | インドール誘導体およびその医薬用途 |
JPH05255089A (ja) | 1991-12-18 | 1993-10-05 | Sanwa Kagaku Kenkyusho Co Ltd | 抗ウイルス剤 |
DE4307883A1 (en) | 1992-03-12 | 1993-09-23 | Westarp Martin Egon Dr Med | Use of anti-retroviral substances - to treat motor-neuronal diseases |
WO1994009781A1 (fr) | 1992-10-28 | 1994-05-11 | The Upjohn Company | Utilisation de composes bhap en combinaison avec d'autres inhibiteurs de la transcriptase inverse non-nucleosidiques dans le traitement des infections a vih |
AU6435594A (en) * | 1993-04-15 | 1994-11-08 | Merck Sharp & Dohme Limited | Indole derivatives as dopamine d4 antagonists |
FR2705095B1 (fr) | 1993-05-12 | 1995-06-23 | Adir | Nouveaux indoles substitués, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent. |
TW270114B (fr) | 1993-10-22 | 1996-02-11 | Hoffmann La Roche | |
US5891902A (en) * | 1994-01-18 | 1999-04-06 | Kyowa Hakko Kogyo Co., Ltd. | Indole derivatives |
JPH09124631A (ja) | 1994-02-03 | 1997-05-13 | Shanxi Chuiyaku Kenkyuin | ベンゾフラン誘導体及びそれを含む医薬組成物 |
EP0782989A4 (fr) | 1995-07-18 | 1999-04-21 | Kyowa Hakko Kogyo Kk | Derives d'indole |
JPH09124609A (ja) | 1995-11-07 | 1997-05-13 | Nissan Chem Ind Ltd | ベンズイミダゾール誘導体 |
TW593290B (en) * | 1996-05-10 | 2004-06-21 | Janssen Pharmaceutica Nv | Alkylaminobenzothiazole and -benzoxazole derivatives |
JPH09325131A (ja) | 1996-06-03 | 1997-12-16 | Japan Steel & Tube Constr Co Ltd | 隅肉溶接部探傷用磁化装置 |
CZ3799A3 (cs) | 1996-07-09 | 1999-08-11 | Smithkline Beecham S. P. A. | Indolový derivát k ošetřování osteoporézy |
BR9811557A (pt) | 1997-08-15 | 2000-08-22 | Pfizer Prod Inc | Derivados do 2-)4-aril ou heteroaril-piperazin-1-ilmetil)-1h-indol |
AU7240398A (en) | 1998-05-08 | 1999-11-29 | Rolf Berge | Use of non-beta-oxidizable fatty acid analogues for treatment of syndrome-x conditions |
EP0978512A1 (fr) | 1998-07-29 | 2000-02-09 | Societe Civile Bioprojet | Non-imidazole aryloxy- (ou arylthio)alkylamines comme antagonistes du recepteur H3 et leur application thérapeutique |
WO2001064676A2 (fr) | 2000-02-28 | 2001-09-07 | Scios, Inc. | INHIBITEURS DE LA P38-α KINASE |
TWI290136B (en) | 2000-04-05 | 2007-11-21 | Daiichi Seiyaku Co | Ethylenediamine derivatives |
JP2003104975A (ja) * | 2001-09-28 | 2003-04-09 | Sumitomo Pharmaceut Co Ltd | 新規なベンゾチアゾール化合物 |
-
2003
- 2003-09-04 CA CA002497827A patent/CA2497827A1/fr not_active Abandoned
- 2003-09-04 PL PL377087A patent/PL377087A1/pl not_active Application Discontinuation
- 2003-09-04 RU RU2005106274/04A patent/RU2005106274A/ru not_active Application Discontinuation
- 2003-09-04 BR BR0314059-8A patent/BR0314059A/pt not_active IP Right Cessation
- 2003-09-04 EP EP03794573A patent/EP1545532A2/fr not_active Withdrawn
- 2003-09-04 JP JP2004534443A patent/JP2006500390A/ja not_active Withdrawn
- 2003-09-04 NZ NZ538401A patent/NZ538401A/en unknown
- 2003-09-04 KR KR1020057003818A patent/KR20050033662A/ko not_active Application Discontinuation
- 2003-09-04 MX MXPA05002575A patent/MXPA05002575A/es unknown
- 2003-09-04 RS YUP-2005/0201A patent/RS20050201A/sr unknown
- 2003-09-04 UA UAA200503209A patent/UA79309C2/uk unknown
- 2003-09-04 US US10/655,381 patent/US7504426B2/en active Active
- 2003-09-04 WO PCT/US2003/027461 patent/WO2004022060A2/fr active Application Filing
- 2003-09-04 CN CNA038249693A patent/CN1694704A/zh active Pending
- 2003-09-04 AU AU2003265886A patent/AU2003265886A1/en not_active Abandoned
- 2003-09-05 AR ARP030103235A patent/AR041170A1/es not_active Application Discontinuation
-
2005
- 2005-02-24 IS IS7716A patent/IS7716A/is unknown
- 2005-03-04 EC EC2005005647A patent/ECSP055647A/es unknown
- 2005-04-05 NO NO20051694A patent/NO20051694L/no not_active Application Discontinuation
- 2005-04-05 ZA ZA200502750A patent/ZA200502750B/en unknown
Also Published As
Publication number | Publication date |
---|---|
PL377087A1 (pl) | 2006-01-23 |
WO2004022060A3 (fr) | 2004-07-08 |
UA79309C2 (en) | 2007-06-11 |
US7504426B2 (en) | 2009-03-17 |
IS7716A (is) | 2005-02-24 |
AU2003265886A1 (en) | 2004-03-29 |
BR0314059A (pt) | 2005-07-05 |
NZ538401A (en) | 2008-03-28 |
WO2004022060A8 (fr) | 2004-06-03 |
RS20050201A (en) | 2007-06-04 |
JP2006500390A (ja) | 2006-01-05 |
EP1545532A2 (fr) | 2005-06-29 |
US20040058934A1 (en) | 2004-03-25 |
CN1694704A (zh) | 2005-11-09 |
WO2004022060A2 (fr) | 2004-03-18 |
ZA200502750B (en) | 2006-06-28 |
MXPA05002575A (es) | 2005-09-08 |
KR20050033662A (ko) | 2005-04-12 |
AR041170A1 (es) | 2005-05-04 |
ECSP055647A (es) | 2005-05-30 |
RU2005106274A (ru) | 2005-11-10 |
CA2497827A1 (fr) | 2004-03-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20051694L (no) | Heterosykliske forbindelser | |
EA200400892A1 (ru) | Производные никотинамида, полезные в качестве ингибиторов pde4 | |
BR0213899A (pt) | Aminopirimidinas e aminopiridinas | |
DK1513826T3 (da) | Hidtil ukendte indolylpiperidinderivater som kraftige antihistamin- og antiallergimidler | |
DE60316013D1 (de) | Heteroaryl-pyrimidinderivate als jak-inhibitoren | |
DK1716152T3 (da) | Kondenserade heterocykliske forbindelser og deres anvendelse som metabotrope receptorantagonister til behandling af gastrointentinde lidelser | |
NO20070122L (no) | Quinazolinonderivater anvendelige som vanilloidantagonister | |
NO20075059L (no) | Nye forbindelser II 2-pyridinderivater som inhibitorer av neutrofil elastase | |
NO20062417L (no) | N-tiazol-2-yl-benzamidderivater | |
NO20092770L (no) | Nye aminopyrimidinderivater som PLK1-inhibitorer | |
NO20052858D0 (no) | Nye tricykliske forbindelser som LTD4-antagonister | |
WO2006100081A3 (fr) | Derives d'indoxyle substitues, medicaments les contenant et leur utilisation | |
DE602004012758D1 (de) | Chinoxalinderivate als inhibitoren der neutrophilelastase und deren verwendung | |
ATE411296T1 (de) | Imidazolinderivate mit cb1-antagonistischer wirkung | |
DK0539086T3 (da) | Kondenserede pyrimidinderivater og deres anvendelse som angiotensin II-antagonister | |
AR056582A1 (es) | COMPUESTOS DE PIRAZOLIL UREA CON ACTIVIDAD INHIBITORIA DE CINASA P38 Y FORMULACIoN FARMACÉUTICA QUE LO COMPRENDE | |
PE20070212A1 (es) | Heterociclos de 1,4-dihidropiridina-condensados, procesos para preparar los mismos, uso y composiciones que los contienen | |
PE20030761A1 (es) | Derivados del 7-amino-benzotiazol | |
TR200103490T2 (tr) | Antihistaminik ve antialerjik maddeler olarak indolilpiperidin türevleri | |
BG94282A (bg) | 2,9-дизаместени-4н-пиридо/1,2,-а/пиримидин-4-они | |
DE60310767D1 (de) | PYRAZOL-3,4-d-PYRIMIDINDERIVATE UND IHRE VERWENDUNG BEI DER BEHANDLUNG VON H.PYLORI-INFEKTIONEN | |
EA200600100A1 (ru) | Производные никотинамида, полезные в качестве ингибиторов pde4 | |
DE602006014576D1 (de) | Zur behandlung von mit trpv1 in zusammenhang stehenden erkrankungen geeignete 2-(benzimidazol-1yl)-n-(4-phenylthiazol-2-yl)acetamidderivate | |
ATE308541T1 (de) | 2-amino-4-heteroarylethyl-thiazolinderivate und ihre verwendung als hemmstoffe der induzierbaren no-synthase | |
ATE329916T1 (de) | Azaindolylpiperidinderivate als antihistaminika und antiallergika |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |